• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/12/25 8:00:00 PM ET
    $ALNY
    $BIIB
    $CDW
    $FER
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ALNY alert in real time by email

    NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NDX®), which will become effective prior to market open on Monday, December 22, 2025.

    The following six companies will be added to the Index: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Ferrovial SE (NASDAQ:FER), Insmed Incorporated (NASDAQ:INSM), Monolithic Power Systems, Inc. (NASDAQ:MPWR), Seagate Technology Holdings plc (NASDAQ:STX), Western Digital Corp. (NASDAQ:WDC).

    The Nasdaq-100 Index is a globally recognized index that tracks the performance of 100 of the largest non-financial companies listed on the Nasdaq Stock Market® encompassing a diverse range of industries and sectors. From technology and retail to healthcare, telecommunications, biotechnology, and media, these companies collectively shape the new 21st century economy. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    As of December 2025, the Nasdaq-100 Index underpins more than 200 tracking products with over $600 billion in assets under management globally, including the Invesco QQQ Trust (QQQ®), which seeks to deliver investment results that, before expenses, correspond to the performance of the Nasdaq-100 Index. In addition to QQQ, a range of derivatives and structured instruments, such as futures, options, and other products based on the Nasdaq-100 Index and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following six companies will be removed from the Index: Biogen Inc. (NASDAQ:BIIB), CDW Corporation (NASDAQ:CDW), GlobalFoundries Inc. (NASDAQ:GFS), Lululemon Athletica Inc. (NASDAQ:LULU), ON Semiconductor Corporation (NASDAQ:ON), The Trade Desk, Inc. (NASDAQ:TTD).

    Information

    For information about the six companies to be added to the Nasdaq-100 Index, please visit the following respective company websites:

    • Alnylam Pharmaceuticals, Inc. – https://www.alnylam.com/
    • Ferrovial SE – https://www.ferrovial.com/
    • Insmed Incorporated – https://insmed.com/
    • Monolithic Power Systems, Inc. – https://www.monolithicpower.com/
    • Seagate Technology Holdings plc – https://www.seagate.com/
    • Western Digital Corp. – https://www.westerndigital.com/



    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Dorsey Wright, Fixed Income (includes BulletShares®), Global Equity, Green Economy, Nordic, and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com

    Nasdaq®, Nasdaq-100 Index®, Nasdaq-100®, NDX®, QQQ®, and Nasdaq Stock Market® are registered trademarks of Nasdaq, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies or Nasdaq proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    Media Relations Contact Investor Relations Contact
    Name: Maximilian Leitenberger

    Email: [email protected]



     Name: Index Client Services

    Email: [email protected]

       

    NDAQF



    Primary Logo

    Get the next $ALNY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALNY
    $BIIB
    $CDW
    $FER

    CompanyDatePrice TargetRatingAnalyst
    Western Digital Corporation
    $WDC
    1/30/2026$200.00 → $325.00Buy
    TD Cowen
    Insmed Incorporated
    $INSM
    1/28/2026$231.00Overweight
    Barclays
    Alnylam Pharmaceuticals Inc.
    $ALNY
    1/28/2026$527.00Overweight
    Barclays
    Seagate Technology Holdings PLC
    $STX
    1/28/2026$340.00 → $500.00Buy
    TD Cowen
    Insmed Incorporated
    $INSM
    1/23/2026$212.00Buy
    Roth Capital
    The Trade Desk Inc.
    $TTD
    1/23/2026Mkt Outperform → Mkt Perform
    Citizens JMP
    ON Semiconductor Corporation
    $ON
    1/22/2026$62.00Underperform → Neutral
    BNP Paribas Exane
    Seagate Technology Holdings PLC
    $STX
    1/21/2026$380.00Neutral → Outperform
    BNP Paribas Exane
    More analyst ratings

    $ALNY
    $BIIB
    $CDW
    $FER
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (ORIG-1) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/12/2024. Application Category: NDA, Application Number: 761347, Application Classification: Type 3 - New Dosage Form

    9/16/24 6:52:10 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (SUPPL-17) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/11/2024. Application Category: NDA, Application Number: 211855, Application Classification: Manufacturing (CMC)

    9/16/24 6:24:32 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for GIVLAARI issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug GIVLAARI (SUPPL-7) with active ingredient GIVOSIRAN SODIUM has changed to 'Approval' on 04/29/2024. Application Category: NDA, Application Number: 212194, Application Classification: Labeling

    4/30/24 1:44:03 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    SEC Filings

    View All

    SEC Form 144 filed by Seagate Technology Holdings PLC

    144 - Seagate Technology Holdings plc (0001137789) (Subject)

    2/2/26 4:34:39 PM ET
    $STX
    Electronic Components
    Technology

    SEC Form 144 filed by Monolithic Power Systems Inc.

    144 - MONOLITHIC POWER SYSTEMS INC (0001280452) (Subject)

    2/2/26 4:02:40 PM ET
    $MPWR
    Semiconductors
    Technology

    SEC Form 144 filed by Biogen Inc.

    144 - BIOGEN INC. (0000875045) (Subject)

    2/2/26 11:10:05 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Japan's Osaka Exchange Adopts Nasdaq Eqlipse Trading and Surveillance Technology for Next-Generation Derivatives Platform

    OSE's technology modernization strengthens Japan's position as a leading global derivatives marketExpands Nasdaq's comprehensive technology partnership across Japan's financial services ecosystem TOKYO and NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Japan Exchange Group's Osaka Exchange (OSE) has selected Nasdaq's advanced Eqlipse Trading and Market Surveillance technology platforms for its next-generation derivatives infrastructure. This strategic technology partnership represents a significant step forward in OSE's modernization journey, positioning Japan's derivatives market for enhanced global competitiveness and future growth opportunities.

    2/4/26 2:18:44 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Western Digital Accelerates Storage Innovation for AI Era

    Now Rebranded as WD, the Company Unveils 100TB+ HDD Roadmap, Performance- and Power-Optimized Hard Drive Breakthroughs, and an Intelligent Platform Solution Redefining Storage Economics and Time-to-Value for Customers Key Highlights: Accelerated high-capacity roadmap: New world's highest capacity 40TB1 UltraSMR ePMR HDD is in customer qualifications now; HAMR HDD capacities scaling to 100TB+ and continued HAMR qualification momentum with hyperscale customers; overlapping technology paths (ePMR and HAMR) give customers choice and flexibility for smooth transitions without disruption New performance drive technology: High Bandwidth Drive and Dual Pivot design technologies deliver 2x b

    2/3/26 4:35:00 PM ET
    $WDC
    Electronic Components
    Technology

    Western Digital Authorizes Additional $4.0 Billion of Share Repurchases

    Western Digital Corporation (NASDAQ:WDC) today announced that its Board of Directors has authorized an additional $4.0 billion for share repurchases by the company pursuant to its share purchase program. As of February 2, 2026, the company had approximately $484 million remaining under the prior share repurchase authorization. The additional repurchase authorization is effective immediately. Share repurchases may be made on the open market or in privately negotiated transactions and may be made pursuant to a Rule 10b5-1 plan. "The expanded $4.0 billion buyback authorization demonstrates our confidence in WD's future and commitment to shareholder value," said CEO Irving Tan. "Our capital a

    2/3/26 8:00:00 AM ET
    $WDC
    Electronic Components
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Davis Tahnil R. claimed ownership of 93,932 units of Class A Common Stock (SEC Form 3)

    3 - Trade Desk, Inc. (0001671933) (Issuer)

    2/3/26 9:22:33 PM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Head of Development Singhal Priya converted options into 1,829 shares, covered exercise/tax liability with 582 shares and sold $134,116 worth of shares (748 units at $179.30), increasing direct ownership by 9% to 6,271 units (SEC Form 4)

    4 - BIOGEN INC. (0000875045) (Issuer)

    2/3/26 5:17:50 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CEO Mosley William D sold $8,585,359 worth of Ordinary Shares (20,000 units at $429.27), decreasing direct ownership by 5% to 410,056 units (SEC Form 4)

    4 - Seagate Technology Holdings plc (0001137789) (Issuer)

    2/3/26 4:48:44 PM ET
    $STX
    Electronic Components
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Western Digital with a new price target

    TD Cowen reiterated coverage of Western Digital with a rating of Buy and set a new price target of $325.00 from $200.00 previously

    1/30/26 6:45:51 AM ET
    $WDC
    Electronic Components
    Technology

    Barclays initiated coverage on Insmed with a new price target

    Barclays initiated coverage of Insmed with a rating of Overweight and set a new price target of $231.00

    1/28/26 7:17:09 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays resumed coverage on Alnylam Pharma with a new price target

    Barclays resumed coverage of Alnylam Pharma with a rating of Overweight and set a new price target of $527.00

    1/28/26 7:15:18 AM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Desjardins Clarissa bought $201,694 worth of shares (3,025 units at $66.68) (SEC Form 4)

    4 - INSMED Inc (0001104506) (Issuer)

    5/22/25 5:20:35 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Reitan Colleen F bought $10,363 worth of shares (36 units at $287.85), sold $8,383 worth of shares (36 units at $232.86) and was granted 775 shares (SEC Form 4)

    4 - ALNYLAM PHARMACEUTICALS, INC. (0001178670) (Issuer)

    5/12/25 4:05:00 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Dorsa Caroline bought $151,559 worth of shares (1,235 units at $122.72), increasing direct ownership by 5% to 27,842 units (SEC Form 4)

    4 - BIOGEN INC. (0000875045) (Issuer)

    5/5/25 4:17:10 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    Leadership Updates

    Live Leadership Updates

    View All

    GlobalFoundries Appoints Ganesh Moorthy to Board of Directors

    MALTA, N.Y., Jan. 15, 2026 (GLOBE NEWSWIRE) -- GlobalFoundries (NASDAQ:GFS) (GF) today announced the appointment of Ganesh Moorthy to its board of directors. Mr. Moorthy, former president and CEO of Microchip Technology Inc., joins GF's Board, effective immediately. Mr. Moorthy brings more than four decades of experience in the semiconductor industry, including transformative leadership at Microchip Technology, where he served as CEO, president and board member until his retirement in November 2024. He was appointed CEO and president in March 2021 and joined Microchip's Board of Directors in January 2021. Prior to that, he held senior leadership roles at Microchip including COO and execut

    1/15/26 8:30:00 AM ET
    $GFS
    Semiconductors
    Technology

    Walmart Inc. to Join the Nasdaq-100 Index® Beginning January 20th, 2026

    NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Walmart Inc. (NASDAQ:WMT), will become a component of the Nasdaq-100 Index® (NDX®), the Nasdaq-100 Equal Weighted™ Index (NDXE™), and the Nasdaq-100 Ex-Tech Sector™ Index (NDXX™) prior to market open on Tuesday, January 20, 2026 - the first trading day following the third Friday of the month. Walmart Inc. will replace AstraZeneca PLC (NASDAQ:AZN) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. AstraZeneca PLC will also be removed from the Nasdaq-100 ESG™ Index (NDXESG™), Nasdaq-100 ex Top 30™​ (NDX70™), Nasdaq-100 ex Top 30​ UCITS™ (NDX70U™), Nasdaq

    1/9/26 8:00:00 PM ET
    $AZN
    $NDAQ
    $WMT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    Nasdaq Maintains Over a Decade of Listings Leadership in 2025

    Largest Exchange Transfer in History & Biggest IPO of the Year Highest Capital Raised Since 2021 - $46.65 Billion Raised NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) announced today that in 2025 it raised a total of $46.65 billion from new listings, marking the strongest year for capital raise since 2021. In addition, 22 companies transferred their corporate listings to Nasdaq in 2025 including Walmart, the largest exchange transfer in history. Since 2005, companies transferring their listing to Nasdaq have represented more than $4 trillion in total market value. "2025 marked a meaningful resurgence for the public markets. Companies at every stage continue to choose

    12/18/25 7:00:00 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $ALNY
    $BIIB
    $CDW
    $FER
    Financials

    Live finance-specific insights

    View All

    Western Digital Accelerates Storage Innovation for AI Era

    Now Rebranded as WD, the Company Unveils 100TB+ HDD Roadmap, Performance- and Power-Optimized Hard Drive Breakthroughs, and an Intelligent Platform Solution Redefining Storage Economics and Time-to-Value for Customers Key Highlights: Accelerated high-capacity roadmap: New world's highest capacity 40TB1 UltraSMR ePMR HDD is in customer qualifications now; HAMR HDD capacities scaling to 100TB+ and continued HAMR qualification momentum with hyperscale customers; overlapping technology paths (ePMR and HAMR) give customers choice and flexibility for smooth transitions without disruption New performance drive technology: High Bandwidth Drive and Dual Pivot design technologies deliver 2x b

    2/3/26 4:35:00 PM ET
    $WDC
    Electronic Components
    Technology

    Western Digital Authorizes Additional $4.0 Billion of Share Repurchases

    Western Digital Corporation (NASDAQ:WDC) today announced that its Board of Directors has authorized an additional $4.0 billion for share repurchases by the company pursuant to its share purchase program. As of February 2, 2026, the company had approximately $484 million remaining under the prior share repurchase authorization. The additional repurchase authorization is effective immediately. Share repurchases may be made on the open market or in privately negotiated transactions and may be made pursuant to a Rule 10b5-1 plan. "The expanded $4.0 billion buyback authorization demonstrates our confidence in WD's future and commitment to shareholder value," said CEO Irving Tan. "Our capital a

    2/3/26 8:00:00 AM ET
    $WDC
    Electronic Components
    Technology

    Western Digital Reports Fiscal Second Quarter 2026 Financial Results

    Q2FY26 Highlights: Revenue of $3.02 billion, up 25% year over year GAAP gross margin of 45.7%; non-GAAP gross margin of 46.1% GAAP diluted EPS of $4.73; non-GAAP diluted EPS of $2.13 Cash flow from operations of $745 million; free cash flow of $653 million Q3FY26 revenue expected to be up approximately 40% year over year at mid-point Western Digital Corporation (NASDAQ:WDC) today reported fiscal second quarter 2026 financial results for the period ended January 2, 2026. "Western Digital's strong performance this quarter reflects our disciplined execution to meet demand in the AI-driven data economy, and the confidence our customers place in our ability to deliver reliabl

    1/29/26 4:05:00 PM ET
    $WDC
    Electronic Components
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Trade Desk Inc.

    SC 13G/A - Trade Desk, Inc. (0001671933) (Subject)

    11/14/24 4:42:28 PM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Insmed Incorporated

    SC 13G/A - INSMED Inc (0001104506) (Subject)

    11/14/24 1:22:37 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Western Digital Corporation

    SC 13G/A - WESTERN DIGITAL CORP (0000106040) (Subject)

    11/14/24 1:22:34 PM ET
    $WDC
    Electronic Components
    Technology